See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: March 21 2008

Cardiac Ischemia Multiple Sclerosis COPD (Chronic Obstructive Pulmonary Disease)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Cardiac Ischemia

You may qualify for this study if you are 18 or older, have atrial fibrillation or flutter, and meet one or more of the following criteria: at least age 75, a history of stroke or blood clots, heart failure, diabetes, or high blood pressure.

The research site is in McKinney, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat446.html.

-----

Multiple Sclerosis

If you have a relapsing form of MS, a screening EDSS score below 6.0, at least one clinical relapse in the 12 months before screening, and have failed beta-interferon treatment, you may qualify for this study.

The research site is in Lenexa, Kansas.

More information

Please see http://www.centerwatch.com/patient/studies/cat102.html.

-----

COPD (Chronic Obstructive Pulmonary Disease)

If you have severe emphysema in most of both lungs, are age 35 or older, are willing to stop smoking at least eight weeks before entering the trial, and meet other eligibility criteria, you may qualify for this study.

The research site is in Winfield, Ill.

More information

Please see http://www.centerwatch.com/patient/studies/cat44.html.

-----

Copyright 2008 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.